Alport Syndrome

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2014-02-11
Clinical Trial Update: Human Urine Sample Collection for Alport Nephropathy Biomarker Studies
A Novartis-sponsored clinical trial studying urine biomarkers for Alport syndrome has terminated, marking the withdrawal of the trial.